All Session Tracks

• Track 01 – Advancements in Tumor Immunology
  This track focuses on the latest discoveries in tumor immunology, including the mechanisms of tumor immune evasion and the role of the tumor microenvironment. Researchers will present novel insights into how tumors manipulate immune responses to promote growth and metastasis. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
• Track 02 – Innovations in Immunotherapy
  This session will explore cutting-edge immunotherapeutic strategies, including checkpoint inhibitors and CAR T-cell therapy, that are transforming cancer treatment. Presentations will highlight clinical outcomes and the underlying immunological principles driving these therapies. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
• Track 03 – Cancer Vaccines: Current Trends and Future Directions
  This track will delve into the development and clinical application of cancer vaccines, emphasizing both preventive and therapeutic approaches. Discussions will include the challenges of vaccine design and the potential for personalized immunization strategies. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
• Track 04 – Immune Checkpoints in Cancer Therapy
  This session will examine the role of immune checkpoint molecules in regulating immune responses against tumors. Researchers will discuss novel checkpoint inhibitors and their implications for enhancing anti-tumor immunity. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
• Track 05 – Cellular and Humoral Immunity in Cancer
  This track will investigate the contributions of both cellular and humoral immunity to cancer progression and therapy. Presentations will focus on the interplay between different immune cell types and their roles in tumor surveillance and eradication. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
• Track 06 – Cytokines and Immune Modulation in Oncology
  This session will highlight the role of cytokines in modulating immune responses in the context of cancer. Researchers will present findings on how cytokine signaling pathways can be targeted to enhance anti-tumor immunity. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
• Track 07 – Monoclonal Antibodies in Cancer Treatment
  This track will explore the development and application of monoclonal antibodies in cancer therapy, including their mechanisms of action and clinical efficacy. Discussions will also address the challenges of resistance and strategies to overcome it. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
• Track 08 – Translational Immunology: Bridging Bench to Bedside
  This session will focus on the translation of immunological research into clinical practice, highlighting successful case studies and ongoing challenges. Presentations will emphasize the importance of collaboration between basic and clinical researchers. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
• Track 09 – Cancer Biomarkers and Immune Evasion
  This track will investigate the identification and validation of cancer biomarkers associated with immune evasion. Researchers will discuss how these biomarkers can inform treatment strategies and predict patient responses to immunotherapy. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
• Track 10 – Molecular Immunology in Cancer Research
  This session will cover the molecular mechanisms underlying immune responses to cancer, including the role of genetic and epigenetic factors. Presentations will highlight innovative approaches to dissecting the molecular landscape of tumor-immune interactions. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
• Track 11 – Future Directions in Immuno-Oncology
  This track will explore emerging trends and future directions in the field of immuno-oncology, including novel therapeutic targets and combination strategies. Researchers will discuss the potential impact of these advancements on cancer treatment paradigms. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure

Alignment with the Sustainable Development Goals
Alongside its academic focus, the conference promotes responsible research, ethical practice and knowledge-driven development. Its session tracks collectively contribute to the following United Nations Sustainable Development Goals.

• SDG 3
  Good Health and Well-being
• SDG 4
  Quality Education
• SDG 9
  Industry, Innovation and Infrastructure